Get our Free Patent Expiration, Litigation, and Drug Price Updates

Serving hundreds of leading biopharmaceutical companies globally:

McKesson
Colorcon
McKinsey
Boehringer Ingelheim
Express Scripts
Federal Trade Commission

Generated: May 24, 2019

DrugPatentWatch Database Preview

Taro Pharm Inds Ltd Company Profile

« Back to Dashboard

What is the competitive landscape for TARO PHARM INDS LTD, and what generic alternatives to TARO PHARM INDS LTD drugs are available?

TARO PHARM INDS LTD has twenty approved drugs.

There are two US patents protecting TARO PHARM INDS LTD drugs.

There are ten patent family members on TARO PHARM INDS LTD drugs in seven countries and nine supplementary protection certificates in four countries.

Summary for Taro Pharm Inds Ltd
International Patents:10
US Patents:2
Tradenames:12
Ingredients:10
NDAs:20

Drugs and US Patents for Taro Pharm Inds Ltd

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Taro Pharm Inds Ltd ACETAMINOPHEN acetaminophen SUPPOSITORY;RECTAL 018337-002 Approved Prior to Jan 1, 1982 OTC Yes No ➤ Sign Up ➤ Sign Up
Taro Pharm Inds Ltd INFANTS' FEVERALL acetaminophen SUPPOSITORY;RECTAL 018337-004 Aug 26, 1992 OTC Yes No ➤ Sign Up ➤ Sign Up
Taro Pharm Inds Ltd TRIAMCINOLONE ACETONIDE triamcinolone acetonide CREAM;TOPICAL 040039-001 Nov 26, 1997 AT RX No No ➤ Sign Up ➤ Sign Up
Taro Pharm Inds Ltd TOPICORT desoximetasone CREAM;TOPICAL 017856-001 Approved Prior to Jan 1, 1982 DISCN Yes No ➤ Sign Up ➤ Sign Up
Taro Pharm Inds Ltd OVIDE malathion LOTION;TOPICAL 018613-001 Aug 2, 1982 AT RX Yes Yes 7,560,445 ➤ Sign Up Y Y ➤ Sign Up
Taro Pharm Inds Ltd TOPICORT desoximetasone OINTMENT;TOPICAL 074286-001 Jun 7, 1996 AB RX No Yes ➤ Sign Up ➤ Sign Up
Taro Pharm Inds Ltd HYDROCORTISONE AND ACETIC ACID acetic acid, glacial; hydrocortisone SOLUTION/DROPS;OTIC 088759-001 Mar 4, 1985 AT RX No No ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

Subscribe to access the full database, or try a Free Trial

Paragraph IV (Patent) Challenges for TARO PHARM INDS LTD drugs
Drugname Dosage Strength Tradename Submissiondate
➤ Subscribe Topical Spray 0.25% ➤ Subscribe 2013-12-18
➤ Subscribe Topical Lotion 0.5% ➤ Subscribe 2011-03-16

Supplementary Protection Certificates for Taro Pharm Inds Ltd Drugs

Patent Number Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
1586316 SPC/GB11/054 United Kingdom ➤ Sign Up PRODUCT NAME: BROMFENAC 2-AMINO-3-(4-BROMOBENZOYL)PHENYLACETIC ACID OR A PHARMACOLOGICALLY ACCEPTABLE SALT THEREOF OR A HYDRATE THEREOF; REGISTERED: UK EU/1/11/692/001 20110523
0809498 SPC/GB10/012 United Kingdom ➤ Sign Up PRODUCT NAME: A COMBINATION OF ACYCLOVIR AND HYDROCORTISONE; REGISTERED: UK PL18191/0001-0001 20091112
0058146 2001C/045 Belgium ➤ Sign Up PRODUCT NAME: DICHLORHYDRATE DE LEVOCETIRIZINE; NAT RER. NO/DATE: 194 IS 90 F3 20011022; FIRST REG.: DE 49903.00.00 20010103
1110543 SPC/GB08/005 United Kingdom ➤ Sign Up SUPPLEMENTARY PROTECTION CERTIFICATE NO SPC/GB08/005 GRANTED TO MERCK SHARP + DOHME CORP. IN RESPECT OF THE PRODUCT DESLORATADINE OPTIONALLY IN THE FORM OF A PHARMACEUTICALLY ACCEPTABLE SALT, IN COMBINATION WITH PSEUDOEPHEDRINE OPTIONALLY IN THE FORM OF A PHARMACEUTICALLY ACCEPTABLE SALT OR ESTER, THE GRANT OF WHICH WAS ADVERTISED IN JOURNAL NO 6322 DATED 21 JULY 2010 HAS HAD ITS MAXIMUM PERIOD OF DURATION CORRECTED, SUBJECT TO THE PAYMENT OF THE PRESCRIBED FEES IT WILL EXPIRE ON 31 JULY 2022.
0152897 2001C/013 Belgium ➤ Sign Up PRODUCT NAME: DESLORATADINE; REGISTRTION NO/DATE: EU/1/00/160/010 20010115
0663828 C300085 Netherlands ➤ Sign Up PRODUCT NAME: LEVOCETIRIZINE, DESGEWENST IN DE VORM VAN EEN FARMACEUTISCH AANVAARDBAAR ZOUT, IN HET BIJZONDER LEVOCETIRINE DIHYDROCHLORIDE; NAT. REGISTRATION NO/DATE: RVG 26770 20011009; FIRST REGISTRATION: DE 49903.00.00 AND 49904.00.00 20010103
0152897 SPC/GB01/012 United Kingdom ➤ Sign Up PRODUCT NAME: DESLORATADINE AND PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF; REGISTERED: UK EU/1/00/157/001-013 20010115; UK EU/1/00/158/001-013 20010115; UK EU/1/00/159/001-013 20010115; UK EU/1/00/160/001-013 20010115; UK EU/1/00/161/001-013 20010115
Patent Number Supplementary Protection Certificate SPC Country SPC Expiration SPC Description

Subscribe to access the full database, or try a Free Trial

Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Cipla
Healthtrust
Fuji
US Army
Covington
Cantor Fitzgerald

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.